Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1833509rdf:typepubmed:Citationlld:pubmed
pubmed-article:1833509lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C0014264lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C0022816lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:1833509lifeskim:mentionsumls-concept:C0132468lld:lifeskim
pubmed-article:1833509pubmed:issue5lld:pubmed
pubmed-article:1833509pubmed:dateCreated1991-11-15lld:pubmed
pubmed-article:1833509pubmed:abstractTextQuinolinic acid, an endogenous excitotoxin, and kynurenic acid, an antagonist of excitatory amino acid receptors, are believed to be synthesized from tryptophan after the opening of the indole ring. They were measured in the rat brain and other organs using gas chromatography-mass spectrometry or HPLC. The enzyme indoleamine 2,3-dioxygenase, capable of cleaving the indole ring of tryptophan, was induced by administering bacterial endotoxins to rats, which significantly increased the brain content of both quinolinic and kynurenic acids. Nicotinylalanine, an analogue of kynurenine, inhibited this endotoxin-induced accumulation of quinolinic acid while potentiating the accumulation of kynurenic acid. The possibility of significantly increasing brain concentrations of kynurenic acid without a concomitant increase in quinolinic acid may provide a useful approach for studying the role of these electrophysiologically active tryptophan metabolites in brain function and preventing the possible toxic actions of abnormal synthesis of quinolinic acid.lld:pubmed
pubmed-article:1833509pubmed:languageenglld:pubmed
pubmed-article:1833509pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:citationSubsetIMlld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1833509pubmed:statusMEDLINElld:pubmed
pubmed-article:1833509pubmed:monthNovlld:pubmed
pubmed-article:1833509pubmed:issn0022-3042lld:pubmed
pubmed-article:1833509pubmed:authorpubmed-author:MoroniFFlld:pubmed
pubmed-article:1833509pubmed:authorpubmed-author:PellicciariRRlld:pubmed
pubmed-article:1833509pubmed:authorpubmed-author:MonetiGGlld:pubmed
pubmed-article:1833509pubmed:authorpubmed-author:RussiPPlld:pubmed
pubmed-article:1833509pubmed:authorpubmed-author:Gallo-MezoM...lld:pubmed
pubmed-article:1833509pubmed:issnTypePrintlld:pubmed
pubmed-article:1833509pubmed:volume57lld:pubmed
pubmed-article:1833509pubmed:ownerNLMlld:pubmed
pubmed-article:1833509pubmed:authorsCompleteYlld:pubmed
pubmed-article:1833509pubmed:pagination1630-5lld:pubmed
pubmed-article:1833509pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:meshHeadingpubmed-meshheading:1833509-...lld:pubmed
pubmed-article:1833509pubmed:year1991lld:pubmed
pubmed-article:1833509pubmed:articleTitleModulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine.lld:pubmed
pubmed-article:1833509pubmed:affiliationDepartment of Preclinical and Clinical Pharmacology, University of Florence, Italy.lld:pubmed
pubmed-article:1833509pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1833509pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1833509lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1833509lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1833509lld:pubmed